Sengenics patented KREX protein folding technology ensures all array proteins are correctly folded, full-length and functional resulting in exceptional binding specificity and inter- & intra-array reproducibility.
Identification of autoantibody biomarker signatures
Predict responders, non-responders and those at risk for adverse events
Intra-disease stratification, identification of cohorts and clinical trial patient enrichment
Establish biomarker signatures for companion diagnostic development
Unique differential profiling of cancer-antigens in various cancer types
Discover how our highly specific protein arrays translates to more accurate results